This is largely consistent with RNA expression data from The Cancer Genome Atlas Research Network (https://www.cancer.gov/tcga), suggesting overwhelmingly high rates and levels of CDH16 expression in renal cell carcinomas and—less frequently and at lower levels—in carcinomas of the thyroid, endometrium, ovary, and the uterine cervix. This evidence concerns the gene CDH16 and hereditary clear cell renal cell carcinoma.